StockData
Accendra Health Inc logo

Accendra Health Inc (ACCH) stock

ACCHWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACH
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

How the market prices Accendra Health

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Accendra Health trades at 53.6× its earnings, against a median of 15.7× since 2016 — dearer than 91% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 15.7×, today 53.6×

What Accendra Health keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin44.1%vs 25.4%
Operating margin0.17%vs 3.34%
EBITDA margin9.21%vs 5.04%
Pretax margin-5.83%vs 3.30%
Net margin-6.72%vs 1.96%
Free cash flow margin-7.80%vs 2.82%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-5.61%vs 2.50%
Return on invested capital0.24%vs 7.00%
Return on capital employed0.30%vs 7.46%

How hard the assets work

Revenue per dollar of assets0.83vs 1.32
Inventory turns a year19.54vs 4.77
Revenue per employee$392.58Kvs $725.35K
Profit per employee-$26.39Kvs $12.19K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $1.73B, or 7.4 times a year of EBITDA. That is 99.4% of the $1.74B it would cost to buy the business outright.

Total debt$1.75B
Cash and short-term investments$26.61M
EBITDA, trailing twelve months$235.12M
Free cash flow, trailing twelve months-$199.12M

Leverage and liquidity

Debt to EBITDA7.46vs 2.00
Net debt to EBITDA7.35vs 1.47
Current ratio0.41vs 2.02
Quick ratio0.04vs 0.99

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

0.20
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

2 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-1716.0%vs 3.50%
Free cash flow yield-1991.7%vs 3.80%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Closing prices adjusted for splits

$0.1252-week low52-week high$4.69
$0.1320-day50-day200-day

The close sits 0% of the way up the 52-week range, 97.2% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

23
OversoldNeutralOverbought

How much it moves

Volatility, 1 year112.7%vs 53.4%
Volume against its 90-day average0.94vs 0.74

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Every measure, in full

85 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 18, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$10.00M
$1.01B
Enterprise Value
$1.74B
$1.44B
PS Ratio
0.00
0.80

Enterprise valuationIndustry

EV / Sales
0.68
0.85
EV / EBITDA
7.39
12.62
EV / EBIT
412.13
15.17

Share statisticsIndustry

Shares Change (YoY)
-0.67%
-0.05%
Shares Change (QoQ)
0.02%
0.02%
Float
61M
35M
Shares Held by Insiders
21.0%
16.0%
Shares Held by Institutions
81.1%
79.6%

Short sellingIndustry

Short Interest
10M
–
Short Interest Change
11.3%
-1.13%
Short % of Float
16.7%
4.81%
Short % of Shares Outstanding
13.2%
3.15%
Days to Cover
4.05
3.77

Stock price statisticsIndustry

52-Week High
$4.69
–
52-Week Low
$0.12
–
20-Day Moving Average
$0.22
–
50-Day Moving Average
$0.51
–
200-Day Moving Average
$2.14
–
Average True Range (14)
$0.05
–
Price Change (1 Week)
-35.0%
-4.41%
Price Change (1 Month)
-50.3%
-5.02%
Price Change (3 Months)
-87.9%
-7.51%
Price Change (6 Months)
-95.5%
-5.13%
Price Change (YTD)
-95.4%
-3.79%
Price Change (1 Year)
-95.6%
-1.41%
Price Change (3 Years)
-99.3%
17.7%
Price Change (5 Years)
-99.7%
2.25%
Price Change (10 Years)
-99.6%
153.1%
Average Volume (10 Days)
6M
–
Average Volume (20 Days)
4M
–
Average Volume (90 Days)
2M
–
Relative Volume
0.94
0.74
Relative Strength Index (14)
22.7
43.9
Volatility (1 Year)
112.7%
53.4%

MarginsIndustry

Gross Margin
44.1%
25.4%
Pretax Margin
-5.83%
3.30%
Profit Margin
-6.72%
1.96%
EBITDA Margin
9.21%
5.04%
FCF Margin
-7.80%
2.82%

Returns on capitalIndustry

Return on Assets (ROA)
-5.61%
2.50%
Return on Invested Capital (ROIC)
0.24%
7.00%
Return on Capital Employed (ROCE)
0.30%
7.46%

Financial positionIndustry

Current Ratio
0.41
2.02
Quick Ratio
0.04
0.99
Debt / EBITDA
7.46
2.00
Net Debt / EBITDA
7.35
1.47
Interest Coverage
0.03
0.93

GrowthIndustry

Revenue Growth (YoY)
-7.14%
6.45%
Revenue Growth (3Y CAGR)
-34.8%
1.68%
Revenue Growth (5Y CAGR)
-20.1%
8.00%

EfficiencyIndustry

Asset Turnover
0.83
1.32
Inventory Turnover
19.54
4.77
Revenue Per Employee
$392.58K
$725.35K
Profits Per Employee
-$26.39K
$12.19K
Employee Count
6,500
787

Income statement (TTM)Industry

Revenue
$2.55B
$1.44B
Gross Profit
$1.13B
$453.14M
Operating Income
$4.22M
$24.33M
Pretax Income
-$148.66M
$20.74M
Net Income
-$171.56M
$11.60M
EBITDA
$235.12M
$66.37M
EPS (Diluted)
-$2.23
$0.58

Balance sheetIndustry

Total Debt
$1.75B
$372.75M
Net Cash (Debt)
-$1.73B
-$872.25K
Net Cash Per Share
-$22.47
-$0.01
Equity (Book Value)
-$568.23M
$230.82M
Book Value Per Share
-$7.39
$17.03
Tangible Book Value
-$1.87B
$43.48M
Working Capital
-$397.58M
$156.44M

Cash flow (TTM)Industry

Operating Cash Flow
-$25.31M
$3.66M
Capital Expenditures
-$173.81M
-$21.01M
Free Cash Flow
-$199.12M
$62.41M
FCF Per Share
-$2.59
$2.35

Dividends and yieldsIndustry

Earnings Yield
-1716.0%
3.50%
FCF Yield
-1991.7%
3.80%

Taxes and interestIndustry

Interest Expense
$132.44M
$14.15M
Income Tax
-$25.72M
$16.39M

Scores and fair valueIndustry

Altman Z-Score
0.20
3.09
Piotroski F-Score
2
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?